Daratumumab, sold under the brand name Darzalex, is an anti-cancer medication. The Food and Drug Administration (FDA) approved Darzalex for the treatment of multiple myeloma. This is a form of a cancer that that affects certain white blood cells called plasma cells. Plasma cells make up a part of your immune system and help fight infections in your body. Treatment durations of up to 25 months have been reported in clinical trials (range 0.1 month to 40.44 months).
Find the Daratumumab Package Insert in PDF BelowDaratumumab Package Insert
SEE: Does H86 Cure Cancer